Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events diabetes and mortality: results from WOSCOPS 15 year follow-up

摘要

AimsThe evidence base for fasting plasma glucose (FPG) in the non-diabetic range as a risk factor for cardiovascular disease (CVD) is inconclusive. We investigated this question in the West of Scotland Coronary Prevention Study (WOSCOPS).